Prelude Capital Management’s Carisma Therapeutics CARM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-532	Closed	-$9K	–	1501
2022 Q2	$9K	Buy	+532	New	+$9K	﹤0.01%	1351